icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
 
 
 
EXPEDITION-I: Efficacy and Safety of Glecaprevir/Pibrentasvir for Treatment of Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection in Adults with Compensated Cirrhosis
 
 
  Reported by Jules Levin
EASL 2017 April 19-21 Amsterdam Netherlands
 
Xavier Forns1, Samuel Lee2, Joaquin Valdes3, Sabela Lens1, Reem Ghalib4, Humberto Aguilar5, Franco Felizarta6, Tarek Hassanein7, Holger Hinrichsen8, Diego Rincon9, Rosa Morillas10, Stefan Zeuzem11, Yves Horsmans12, David Nelson13, Yao Yu3, Preethi Krishnan3, Chih-Wei Lin3, Federico Mensa3
 
1Liver Unit, Hospital Clinic, CIBEREHD, IDIBAPS, Barcelona, Spain; 2University of Calgary, Alberta, Canada; 3AbbVie Inc., North Chicago, IL, USA; 4Texas Digestive Disease Consultants, Arlington, Texas, USA; 5Louisiana Research Center, LLC, Shreveport, LA, USA; 6Private Practice, Bakersfield, California, USA; 7Southern California Liver Centers and Southern California Research Center, Coronado, USA; 8Gastroenterology-Hepatology Center Kiel, Kiel, Germany; 9Liver Unit, Hospital General Universitario Gregorio Mara˝ˇn, CIBERehd, Madrid, Spain; 10Liver Section and CIBERehd, Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; 12J.W. Goethe University, Frankfurt, Germany; 13Cliniques Universitaires Saint-Luc, UniversitÚ Catholique de Louvain, Brussels, Belgium; 14Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA

0421171

0421172

0421173

0421174

0421175

0421176